ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,250.79
      1.72%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      05/01/20197:18AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/01/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides a Business UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20195:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20195:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20195:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20195:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20195:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20195:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20195:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20195:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20192:51PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/201911:40AMDow Jones NewsLexicon Pharmaceuticals Up 7% After EU Approval for Diabetes TreatmentNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/26/20195:21PMDow Jones NewsEuropean Health Regulators Approve Oral Treatment for Type 1 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/26/20194:01PMGlobeNewswire Inc.Zynquista™ now Approved in the European Union for Treatment of Adults With Type 1 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/26/20196:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/25/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host First Quarter 2019 Financial Results Conference Call and Webcast on May 1, 2019NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/10/20198:45AMGlobeNewswire Inc.Consolidated Research: 2019 Summary Expectations for Splunk, Lexicon Pharmaceuticals, Cognizant Technology Solutions, QAD, Wa...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/02/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/25/201911:20AMDow Jones NewsLexicon Pharma Shares Down Almost 10% on FDA RejectionNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/22/20197:57PMDow Jones NewsFDA Rejects Oral Treatment for Type 1 Diabetes - UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/22/20193:43PMDow Jones NewsFDA Rejects Oral Treatment for Type 1 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/22/20192:16PMGlobeNewswire Inc.FDA Issues Complete Response Letter for Zynquista™ (sotagliflozin)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/22/20192:16PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Conference Call and Webcast Today, March 22, 2019 to Provide a Regulatory Update on Sotaglifl...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/15/201910:39AMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Dosing of First Patient in TELE-ABC Study, a Phase 2a Clinical Study of Telotristat Ethyl i...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/15/20196:18AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/15/20196:14AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/15/20196:10AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/13/20197:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/13/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides a Business UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/11/201912:00PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2018 Financial Results Conference Call and Webcast on March 13, ...NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX